Composition:
Each bilayered tablet contains:

• Telmisartan 40 mg

• Metformin Hydrochloride (Extended Release) 500 mg

Description:
Mistand-M2 is a bilayered tablet that combines Telmisartan, an angiotensin II receptor blocker (ARB), and Metformin, a biguanide antidiabetic agent. This formulation is specially designed for patients with type 2 diabetes mellitus and coexisting hypertension, helping to manage both blood pressure and blood glucose effectively.